Literature DB >> 26016926

Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence.

Masatoshi Miyamura1, Shu-ichi Fujita, Hideaki Morita, Kazushi Sakane, Yusuke Okamoto, Koichi Sohmiya, Masaaki Hoshiga, Nobukazu Ishizaka.   

Abstract

BACKGROUND: Atrial fibrillation (AF) occurs more frequently among patients with renal dysfunction. We investigated the possible association between prevalence of AF and serum fibroblast growth factor 23 (FGF23), which has been shown to be increased in subjects with renal dysfunction. METHODS AND
RESULTS: Among the total enrollment of 851 cardiac patients, 188 patients had AF (paroxysmal AF, 95; non-paroxysmal AF, 93). Prevalence of AF for FGF23 octile had a U-shaped relationship with the lowest prevalence at the fifth octile. On logistic regression analysis, when the third FGF23 quartile was used as the reference, the first and fourth FGF23 quartiles were associated with prevalence of AF with an odds ratio (OR) of 3.34 (95% confidence interval [CI]: 1.89-5.88) and 2.58 (95% CI: 1.45-4.58), respectively, after adjusting for confounding factors including estimated glomerular filtration rate (eGFR). Among the subgroup of 416 patients for whom serum parathyroid hormone and 25-hydroxy vitamin D data were available, OR of the first and the fourth FGF23 quartile were calculated to be 3.52 and 2.97, respectively, when further adjusted for these two variables in the statistical model.
CONCLUSIONS: Serum FGF23 had a U-shaped relationship with prevalence of AF among Japanese cardiac patients, which was independent of other calcium/phosphate metabolism-related parameters and eGFR. Pathophysiology underlying the observed link, if at all, awaits further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26016926     DOI: 10.1253/circj.CJ-15-0413

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  Role of fibroblast growth factor-23 (FGF-23) in the prediction of postoperative atrial fibrillation after coronary artery bypass surgery.

Authors:  Kartik Pandurang Jadhav; Praveen Gopalakrishna Pai; Indu Nair; Sajitha Krishnan; Praveen Kerala Varma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-10

2.  Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Authors:  Dominique Kosk; Holly Kramer; Amy Luke; Pauline Camacho; Pascal Bovet; Jacob Plange Rhule; Terrence Forrester; Myles Wolf; Chris Sempos; Michal L Melamed; Lara R Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

3.  Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.

Authors:  Shennin N Yuen; Holly Kramer; Amy Luke; Pascal Bovet; Jacob Plange-Rhule; Terrence Forrester; Vicki Lambert; Myles Wolf; Pauline Camacho; Regina Harders; Lara Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Clin Endocrinol Metab       Date:  2016-03-22       Impact factor: 5.958

4.  Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.

Authors:  Jonah M Graves; Julian A Vallejo; Chelsea S Hamill; Derek Wang; Rohan Ahuja; Shaan Patel; Christian Faul; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-30       Impact factor: 5.125

5.  Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.

Authors:  Clotilde Roy; Sibille Lejeune; Alisson Slimani; Christophe de Meester; Sylvie A Ahn As; Michel F Rousseau; Amzulescu Mihaela; Audrey Ginion; Benjamin Ferracin; Agnès Pasquet; David Vancraeynest; Christophe Beauloye; Jean-Louis Vanoverschelde; Sandrine Horman; Damien Gruson; Bernhard L Gerber; Anne-Catherine Pouleur
Journal:  ESC Heart Fail       Date:  2020-06-24

6.  Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis.

Authors:  Ziqi Tan; Tiangang Song; Shanshan Huang; Menglu Liu; Jianyong Ma; Jing Zhang; Peng Yu; Xiao Liu
Journal:  Front Cardiovasc Med       Date:  2022-08-04

7.  Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.

Authors:  Noboru Ichihara; Masatoshi Miyamura; Daichi Maeda; Tomohiro Fujisaka; Shu-Ichi Fujita; Hideaki Morita; Yoshihiro Takeda; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  J Arrhythm       Date:  2017-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.